These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 18383901)
1. Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression. Marioni G; Giacomelli L; D'Alessandro E; Staffieri C; Guzzardo V; Staffieri A; Blandamura S Anticancer Res; 2008; 28(1B):551-7. PubMed ID: 18383901 [TBL] [Abstract][Full Text] [Related]
2. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival. Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379 [TBL] [Abstract][Full Text] [Related]
3. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related]
4. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma. Marioni G; Ottaviano G; Giacomelli L; Staffieri C; Casarotti-Todeschini S; Bonandini E; Staffieri A; Blandamura S Eur J Surg Oncol; 2006 Dec; 32(10):1149-53. PubMed ID: 16979866 [TBL] [Abstract][Full Text] [Related]
5. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression. Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202 [TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma. Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216 [TBL] [Abstract][Full Text] [Related]
7. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma. Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405 [TBL] [Abstract][Full Text] [Related]
8. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma. Zvrko E; Mikic A; Vuckovic L Eur Arch Otorhinolaryngol; 2009 Dec; 266(12):1971-6. PubMed ID: 19340447 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC; Bleil CB; Hilbig A; Coutinho LM Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma. Zvrko E; Mikic A; Vuckovic L Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823 [TBL] [Abstract][Full Text] [Related]
12. High expression of CD105 as a prognostic predictor of early tongue cancer. Chuang HC; Su CY; Huang HY; Chien CY; Chen CM; Huang CC Laryngoscope; 2006 Jul; 116(7):1175-9. PubMed ID: 16826056 [TBL] [Abstract][Full Text] [Related]
13. Elderly patients at higher risk of laryngeal carcinoma recurrence could be identified by a panel of two biomarkers (nm23-H1 and CD105) and pN+ status. Lovato A; Marioni G; Manzato E; Staffieri C; Giacomelli L; Ralli G; Staffieri A; Blandamura S Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3417-24. PubMed ID: 25280747 [TBL] [Abstract][Full Text] [Related]
14. Role of tumor suppressor and angiogenesis markers in prediction of recurrence of non muscle invasive bladder cancer. Agrawal U; Mishra AK; Salgia P; Verma S; Mohanty NK; Saxena S Pathol Oncol Res; 2011 Mar; 17(1):91-101. PubMed ID: 20571940 [TBL] [Abstract][Full Text] [Related]
15. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881 [TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063 [TBL] [Abstract][Full Text] [Related]
17. The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study. Marioni G; Staffieri A; Fasanaro E; Stramare R; Giacomelli L; Bernardi E; Val M; Stellini E; de Filippis C; Blandamura S J Oral Pathol Med; 2013 Sep; 42(8):606-11. PubMed ID: 23432607 [TBL] [Abstract][Full Text] [Related]
18. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance. Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features. Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582 [TBL] [Abstract][Full Text] [Related]
20. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O Pathol Int; 2006 Dec; 56(12):717-23. PubMed ID: 17096728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]